Our finding is in agreement with the study by Terai et al.60, showing that CRISPR/Cas9-mediated knockout of ufmylation genes in lung cancer cells specifically activated the IRE1α-Xbp1 branch. This evidence concerns the gene ERN1 and lung carcinoma.